These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33913648)

  • 21. [The polypill as cardiovascular prophylactic: clinical trials].
    Sandli OK; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2014 Mar; 134(6):620-3. PubMed ID: 24670510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of polypill components in patients with type 2 diabetes mellitus.
    Janssen VE; Visseren FL; de Boer A; Grobbee DE; Westerink J; van der Graaf Y; Lafeber M;
    Eur J Prev Cardiol; 2018 Sep; 25(14):1523-1531. PubMed ID: 30033753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol.
    Merat S; Poustchi H; Hemming K; Jafari E; Radmard AR; Nateghi A; Shiravi Khuzani A; Khoshnia M; Marshall T; Malekzadeh R
    Arch Iran Med; 2015 Aug; 18(8):515-23. PubMed ID: 26265520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill.
    Lafeber M; Spiering W; Visseren FL; Grobbee DE
    Curr Hypertens Rep; 2016 Apr; 18(5):40. PubMed ID: 27083928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.
    Singh K; Crossan C; Laba TL; Roy A; Hayes A; Salam A; Jan S; Lord J; Tandon N; Rodgers A; Patel A; Thom S; Prabhakaran D
    Int J Cardiol; 2018 Jul; 262():71-78. PubMed ID: 29622506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus.
    Lafeber M; Grobbee DE; Spiering W; van der Graaf Y; Bots ML; Visseren FL;
    Eur J Prev Cardiol; 2013 Oct; 20(5):771-8. PubMed ID: 22649123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of polypill difficult to demonstrate from varied studies, say Cochrane reviewers.
    Torjesen I
    BMJ; 2014 Apr; 348():g2819. PubMed ID: 24742603
    [No Abstract]   [Full Text] [Related]  

  • 29. Fixed-dose combination therapy (polypill) for the prevention of cardiovascular disease.
    Huffman MD; de Cates AN; Ebrahim S
    JAMA; 2014 Nov; 312(19):2030-1. PubMed ID: 25399279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The concept of the polypill in the prevention of cardiovascular disease.
    Wiley B; Fuster V
    Ann Glob Health; 2014; 80(1):24-34. PubMed ID: 24751562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Komentář ke článku HOPE-3: Statins Lower CV Events in Intermediate-CHD-Risk Patients].
    Widimský J
    Vnitr Lek; 2016; 62(6):474-6. PubMed ID: 27485846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.
    Patel A; Shah T; Shah G; Jha V; Ghosh C; Desai J; Khamar B; Chakraborty BS
    Am J Cardiovasc Drugs; 2010; 10(2):95-103. PubMed ID: 20334446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.
    Malekzadeh F; Marshall T; Pourshams A; Gharravi M; Aslani A; Nateghi A; Rastegarpanah M; Khoshnia M; Semnani S; Salahi R; Thomas GN; Larijani B; Cheng KK; Malekzadeh R
    Int J Clin Pract; 2010 Aug; 64(9):1220-7. PubMed ID: 20653798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polypill remains the only panacea in sight for cardiovascular disease, trial organiser says.
    Hawkes N
    BMJ; 2012 Jul; 345():e4837. PubMed ID: 22807080
    [No Abstract]   [Full Text] [Related]  

  • 35. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.
    Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL
    Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The polypill to prevent cardiovascular disease: physicians' perspectives.
    Viera AJ
    Curr Opin Cardiol; 2011 Sep; 26(5):438-42. PubMed ID: 21730826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Polypill - A Practicable Approach?].
    Thürmann PA; Kleinerüschkamp AG; Boehme P
    Dtsch Med Wochenschr; 2019 Jun; 144(11):715-718. PubMed ID: 31163467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the cardiovascular polypill 40mg in secondary cardiovascular prevention.
    Marzal D; Rodríguez Padial L; Arnáiz JA; Castro A; Cosín J; Lekuona I; Guijarro C
    Clin Investig Arterioscler; 2018; 30(5):240-247. PubMed ID: 30017176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconsidering the Polypill for Management of Cardiovascular Risk Factors in Underserved Patients.
    Macaulay TE; Sheridan E; Ward S
    Curr Cardiol Rep; 2021 Feb; 23(3):19. PubMed ID: 33598864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial.
    Laba TL; Hayes A; Lo S; Peiris DP; Usherwood T; Hillis GS; Rafter N; Reid CM; Tonkin AM; Webster R; Neal BC; Cass A; Patel A; Rodgers A; Jan S
    Med J Aust; 2014 Dec; 201(11):671-3. PubMed ID: 25495315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.